Literature DB >> 31055952

Strong Relationship Between Vascular Function in the Coronary and Brachial Arteries.

Ryan M Broxterman1,2, Melissa A Witman3, Joel D Trinity1,4,5,2, H Jonathan Groot6, Matthew J Rossman7, Song-Young Park8, Simon Malenfant1, Jayson R Gifford9, Oh Sung Kwon10, Soung Hun Park4, Catherine L Jarrett1,2, Katherine L Shields4, Jay R Hydren4, Angela V Bisconti11, Theophilus Owan1, Anu Abraham1, Anwar Tandar1, Charles Y Lui1, Brigham R Smith1, Russell S Richardson1,4,5,2.   

Abstract

Early detection of coronary artery dysfunction is of paramount cardiovascular clinical importance, but a noninvasive assessment is lacking. Indeed, the brachial artery flow-mediated dilation test only weakly correlated with acetylcholine-induced coronary artery function ( r=0.36). However, brachial artery flow-mediated dilation methodologies have, over time, substantially improved. This study sought to determine if updates to this technique have improved the relationship with coronary artery function and the noninvasive indication of coronary artery dysfunction. Coronary artery and brachial artery function were assessed in 28 patients referred for cardiac catheterization (61±11 years). Coronary artery function was determined by the change in artery diameter with a 1.82 μg/min intracoronary acetylcholine infusion. Based on the change in vessel diameter, patients were characterized as having dysfunctional coronary arteries (>5% vasoconstriction) or relatively functional coronary arteries (<5% vasoconstriction). Brachial artery function was determined by flow-mediated dilation, adhering to current guidelines. The acetylcholine-induced change in vessel diameter was smaller in patients with dysfunctional compared with relatively functional coronary arteries (-11.8±4.6% versus 5.8±9.8%, P<0.001). Consistent with this, brachial artery flow-mediated dilation was attenuated in patients with dysfunctional compared with relatively functional coronaries (2.9±1.9% versus 6.2±4.2%, P=0.007). Brachial artery flow-mediated dilation was strongly correlated with the acetylcholine-induced change in coronary artery diameter ( r=0.77, P<0.0001) and was a strong indicator of coronary artery dysfunction (receiver operator characteristic=78%). The current data support that updates to the brachial artery flow-mediated dilation technique have strengthened the relationship with coronary artery function, which may now provide a clinically meaningful indication of coronary artery dysfunction.

Entities:  

Keywords:  acetylcholine; brachial artery; catheterization; endothelium; vasodilation

Mesh:

Substances:

Year:  2019        PMID: 31055952      PMCID: PMC6716528          DOI: 10.1161/HYPERTENSIONAHA.119.12881

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  46 in total

1.  Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease.

Authors:  J A Vita; C B Treasure; E G Nabel; J M McLenachan; R D Fish; A C Yeung; V I Vekshtein; A P Selwyn; P Ganz
Journal:  Circulation       Date:  1990-02       Impact factor: 29.690

Review 2.  Assessment of flow-mediated dilation in humans: a methodological and physiological guideline.

Authors:  Dick H J Thijssen; Mark A Black; Kyra E Pyke; Jaume Padilla; Greg Atkinson; Ryan A Harris; Beth Parker; Michael E Widlansky; Michael E Tschakovsky; Daniel J Green
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-15       Impact factor: 4.733

Review 3.  Flow-mediated dilation and cardiovascular event prediction: does nitric oxide matter?

Authors:  Daniel J Green; Helen Jones; Dick Thijssen; N T Cable; Greg Atkinson
Journal:  Hypertension       Date:  2011-01-24       Impact factor: 10.190

4.  Heterogenous nature of flow-mediated dilatation in human conduit arteries in vivo: relevance to endothelial dysfunction in hypercholesterolemia.

Authors:  M J Mullen; R K Kharbanda; J Cross; A E Donald; M Taylor; P Vallance; J E Deanfield; R J MacAllister
Journal:  Circ Res       Date:  2001-02-02       Impact factor: 17.367

Review 5.  Non-invasive endothelial function testing and the risk of adverse outcomes: a systematic review and meta-analysis.

Authors:  Yang Xu; Rakesh C Arora; Brett M Hiebert; Blake Lerner; Andrea Szwajcer; Kerry McDonald; Claudio Rigatto; Paul Komenda; Manish M Sood; Navdeep Tangri
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-01-07       Impact factor: 6.875

6.  Vascular function and endothelin-1: tipping the balance between vasodilation and vasoconstriction.

Authors:  Steven K Nishiyama; Jia Zhao; D Walter Wray; Russell S Richardson
Journal:  J Appl Physiol (1985)       Date:  2016-12-01

7.  Prognostic value of coronary vascular endothelial dysfunction.

Authors:  Julian P J Halcox; William H Schenke; Gloria Zalos; Rita Mincemoyer; Abhiram Prasad; Myron A Waclawiw; Khaled R A Nour; Arshed A Quyyumi
Journal:  Circulation       Date:  2002-08-06       Impact factor: 29.690

8.  Close relation of endothelial function in the human coronary and peripheral circulations.

Authors:  T J Anderson; A Uehata; M D Gerhard; I T Meredith; S Knab; D Delagrange; E H Lieberman; P Ganz; M A Creager; A C Yeung
Journal:  J Am Coll Cardiol       Date:  1995-11-01       Impact factor: 24.094

Review 9.  Cholinergic constriction in the general circulation and its role in coronary artery spasm.

Authors:  S Kalsner
Journal:  Circ Res       Date:  1989-08       Impact factor: 17.367

10.  Isolated human coronary arteries in response to vasoconstrictor substances.

Authors:  N Toda
Journal:  Am J Physiol       Date:  1983-12
View more
  19 in total

Review 1.  Physiological Impact and Clinical Relevance of Passive Exercise/Movement.

Authors:  Joel D Trinity; Russell S Richardson
Journal:  Sports Med       Date:  2019-09       Impact factor: 11.136

2.  Imaging transcranial Doppler ultrasound to measure middle cerebral artery blood flow: the importance of measuring vessel diameter.

Authors:  Catherine L Jarrett; Katherine L Shields; Ryan M Broxterman; Jay R Hydren; Soung Hun Park; Jayson R Gifford; Russell S Richardson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-05-13       Impact factor: 3.619

3.  Influence of dietary inorganic nitrate on blood pressure and vascular function in hypertension: prospective implications for adjunctive treatment.

Authors:  Ryan M Broxterman; D Taylor La Salle; Jia Zhao; Van R Reese; Russell S Richardson; Joel D Trinity
Journal:  J Appl Physiol (1985)       Date:  2019-08-15

4.  Spinal cord injury and vascular function: evidence from diameter-matched vessels.

Authors:  Massimo Venturelli; Markus Amann; Joel D Trinity; Stephen J Ives; Russell S Richardson
Journal:  J Appl Physiol (1985)       Date:  2020-12-03

5.  Associations between noninvasive upper- and lower-limb vascular function assessments: extending the evidence to young women.

Authors:  Michele N D'Agata; Elissa K Hoopes; Melissa A Witman
Journal:  J Appl Physiol (1985)       Date:  2022-08-25

6.  Differential effects of tobacco cigarettes and electronic cigarettes on endothelial function in healthy young people.

Authors:  Kacey P Haptonstall; Yasmine Choroomi; Roya Moheimani; Kevin Nguyen; Elizabeth Tran; Karishma Lakhani; Isabella Ruedisueli; Jeffrey Gornbein; Holly R Middlekauff
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-07-31       Impact factor: 4.733

7.  Nitric oxide synthase inhibition with N(G)-monomethyl-l-arginine: Determining the window of effect in the human vasculature.

Authors:  Andrew C Kithas; Ryan M Broxterman; Joel D Trinity; Jayson R Gifford; Oh Sung Kwon; Jay R Hydren; Ashley D Nelson; Jacob E Jessop; Amber D Bledsoe; David E Morgan; Russell S Richardson
Journal:  Nitric Oxide       Date:  2020-09-24       Impact factor: 4.427

8.  Markers of Cardiovascular Health in Older Adults with and Without Chronic Low Back and Radicular Leg Pain: A Comparative Analysis.

Authors:  Peter C Coyle; Victoria A O'Brien; David G Edwards; Ryan T Pohlig; Gregory E Hicks
Journal:  Pain Med       Date:  2021-06-04       Impact factor: 3.750

9.  No effect of acute tetrahydrobiopterin (BH4) supplementation on vascular dysfunction in the old.

Authors:  Angela V Bisconti; Ryan S Garten; Ryan M Broxterman; Catherine L Jarrett; Soung Hun Park; Katherine L Shields; Heather L Clifton; Stephen M Ratchford; Van Reese; Jia Zhao; D Walter Wray; Russell S Richardson
Journal:  J Appl Physiol (1985)       Date:  2022-02-03

10.  Sacubitril-valsartan improves conduit vessel function and functional capacity and reduces inflammation in heart failure with reduced ejection fraction.

Authors:  Kanokwan Bunsawat; Stephen M Ratchford; Jeremy K Alpenglow; Soung Hun Park; Catherine L Jarrett; Josef Stehlik; Adam S Smith; Russell S Richardson; D Walter Wray
Journal:  J Appl Physiol (1985)       Date:  2020-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.